Cargando…
Delivery and Biosafety of Oncolytic Virotherapy
In recent years, oncolytic virotherapy has emerged as a promising anticancer therapy. Oncolytic viruses destroy cancer cells, without damaging normal tissues, through virus self-replication and antitumor immunity responses, showing great potential for cancer treatment. However, the clinical guidelin...
Autores principales: | Li, Lizhi, Liu, Shixin, Han, Duoduo, Tang, Bin, Ma, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176816/ https://www.ncbi.nlm.nih.gov/pubmed/32373515 http://dx.doi.org/10.3389/fonc.2020.00475 |
Ejemplares similares
-
Implications of MicroRNAs in Oncolytic Virotherapy
por: Bofill-De Ros, Xavier, et al.
Publicado: (2017) -
Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
por: Meyers, Daniel E., et al.
Publicado: (2017) -
Immune System, Friend or Foe of Oncolytic Virotherapy?
por: Filley, Anna C., et al.
Publicado: (2017) -
Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
por: Nguyen, Andrew, et al.
Publicado: (2014) -
Oncolytic virotherapy for metastatic breast cancer – a case report
por: Gesundheit, Benjamin, et al.
Publicado: (2023)